Medical News, Journals & Upcoming Events
Most Read Psychiatry Articles on JAMA Network
- The Promise and Perils of Using Peers and Other Paraprofessionals as Mental Health Service Professionals January 2, 2025This Viewpoint discusses better integration of peer support specialists and other paraprofessionals into clinical and community practice settings to help address the behavioral health workforce shortage.
- Social Determinants of Health and Suicide-Related Outcomes January 2, 2025This review of meta-analyses examines data from meta-analyses reporting associations between social determinants of health and suicide-related outcomes to determine which factors are most strongly associated with suicide risk.
- Requests for Medical Assistance in Dying by Young Dutch People With Psychiatric Disorder January 2, 2025This cohort study examines outcomes of requests for medical assistance in dying among Dutch young people with psychiatric disorders.
- Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder January 1, 2025This cohort study examines nationwide registry data for Swedish residents with a diagnosis of alcohol use disorder to determine whether hospitalization risk for an individual is decreased during periods of GLP-1 agonist use vs periods of nonuse.
- Antipsychotic Drugs and Cognitive Function January 1, 2025This systematic review and network meta-analysis evaluates associations between antipsychotic drugs and cognitive function, quality of life, and social functioning.
JAMA Oncology Current Issue
- Endometrial Cancer Classification and Management in the Molecular Subtyping Era December 1, 2024A 65-year-old woman presented with a 6-month history of postmenopausal vaginal bleeding, and endometrial biopsy showed grade 2 endometrioid adenocarcinoma. What would you do next?
- Natural Language Processing–Assessed Unmet Medical and Social Needs December 1, 2024This cross-sectional study uses a large natural language processing model to examine unmet medical and social needs based on cancer-related fundraising stories in the US.
- Comment on Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer December 1, 2024To the Editor A recently published article sparked our interest. The meta-analysis included 24 randomized clinical trials and conducted a random-effects meta-analysis to estimate risk ratios for the incidence of primary outcomes. The conclusion was that addition of androgen receptor–signaling inhibitors to traditional androgen deprivation therapy was associated with an increased risk of cardiovascular events […]
- Comment on Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer—Reply December 1, 2024In Reply We appreciate the interest in our recently published article. We thank Tang et al for their careful review of our meta-analysis of 24 randomized clinical trials that assessed the incidence of cardiovascular events with the addition of androgen receptor–signaling inhibitors to standard of care in locally advanced and metastatic prostate cancer.
Upcoming Events
To receive information about upcoming events and the latest CE Activities, join our network.
